GGrantIndex
Sort

46,585 grants matching heart failure

AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES

$431,269
Robert B Banzett · Beth Israel Deaconess Medical Center · R01 · FY2015 · NR

Alpha-Catenins in Mechanochemical Signaling

$431,251
Glenn Lawrence Radice · Thomas Jefferson University · R56 · FY2015 · HL

Regulation of Heart Function by a Gata4-Fog2 transcriptional complex

$431,250
William T Pu · Boston Children'S Hospital · R01 · FY2011 · HL

Myofibril disassembly during neonatal heart muscle cell proliferation

$431,250
Bernhard Kuhn · Boston Children'S Hospital · R01 · FY2011 · HL

Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension

$431,210
Anna R Hemnes · Vanderbilt University Medical Center · R01 · FY2018 · HL

Natriuretic Peptide System and Cardiomyocytes Biology

$431,152
Margaret M Redfield · Mayo Clinic Rochester · P01 · FY2007 · HL

Long Non-coding RNA as Mediators of Metabolic Disease

$431,142
Jane E Freedman · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · HL

Molecular Physiology of Myocardial Troponin I Variants

$431,138
Anne M Murphy · Johns Hopkins University · R01 · FY2011 · HL

Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults

$431,134
Douglas R Seals · University Of Colorado · R01 · FY2022 · AG

NO signaling by a Soluble Guanylyl Cyclase -Thioredoxin transnitrosation complex

$431,133
Annie V Beuve · Rutgers Biomedical And Health Sciences · R01 · FY2023 · GM

Transcatheter Strategies for Leaflet Extension to Treat Mitral Regurgitation

$431,116
Sai Muralidhar Padala · Emory University · R01 · FY2017 · HL

Cardiovascular Stiffening in Aged Patients with CHF

$431,111
Johns Hopkins University · R01 · FY2004 · AG

Cardiovascular Consequences of Peptidase Inhibition

$431,108
Nancy Joan Brown · Vanderbilt University Medical Center · R01 · FY2016 · HL

Central Limitations to Exercise Performance in HFpEF

$431,103
Benjamin D Levine · Ut Southwestern Medical Center · P01 · FY2022 · HL

Which Post-Acute Care Setting is Best for Patients' Outcomes?

$431,082
Pedro L Gozalo · Brown University · R01 · FY2018 · AG

Angiotensin Converting Enzyme Gene Expression

$431,053
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · HL

Regulation of Mitochondrial Function by Orphan Protein Phosphatases

$431,047
David J Pagliarini · Washington University · R01 · FY2022 · DK

Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis

$431,046
Lorraine B Ware · Vanderbilt University Medical Center · R01 · FY2024 · HL

Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis

$431,046
Lorraine B Ware · Vanderbilt University Medical Center · R01 · FY2025 · HL

Gene Function, Expression and Regulation in Zebrafish

$431,031
Benjamin Feldman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIC · FY2015 · HD

Beat to beat Ca2+-dependent regulation of pacemaker cell rate and rhythm

$431,026
Edward Lakatta · National Institute On Aging · ZIA · FY2024 · AG

Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes

$431,022
Rodica Pop-Busui · University Of Michigan At Ann Arbor · R01 · FY2014 · HL

Targeted Systemic Delivery of SDF-1 DNA for the Treatment of Chronic Heart Disease

$430,962
Young-Wook Won · University Of Arizona · R01 · FY2018 · HL

Myoarchitectural Basis of Heart Failure

$430,953
Richard J Gilbert · Ocean State Research Institute, Inc. · R56 · FY2018 · HL

Apo-B Domains and Lipoprotein Structure and Assembly

$430,939
Donald M Small · Boston University Medical Campus · P01 · FY2006 · HL